[HTML][HTML] HDL action on the vascular wall: is the answer NO?
PW Shaul, C Mineo - The Journal of clinical investigation, 2004 - Am Soc Clin Investig
PW Shaul, C Mineo
The Journal of clinical investigation, 2004•Am Soc Clin InvestigCirculating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and
therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study
shows that HDL-associated lysophospholipids stimulate the production of the potent
antiatherogenic signaling molecule NO by the vascular endothelium.
therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study
shows that HDL-associated lysophospholipids stimulate the production of the potent
antiatherogenic signaling molecule NO by the vascular endothelium.
Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.
The Journal of Clinical Investigation